Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MVA.HIVconsvX vaccination-evoked T cell expansion inversely associates with age in people with HIV-1 on antiretroviral therapy.

The Journal of clinical investigation·2026
Same author

Efficacy of Combination Treatment for Cervical Precancer Among Women Living with HIV in South Africa: Secondary Outcomes from the ACT 2 Randomized Controlled Trial.

medRxiv : the preprint server for health sciences·2026
Same author

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among Women Living with HIV in South Africa: Primary Outcomes from the ACT 2 Randomized Trial.

medRxiv : the preprint server for health sciences·2026
Same author

Serologic Evidence of Hemorrhagic Fever Virus Spillover in Rural Liberia.

Open forum infectious diseases·2026
Same author

Randomized clinical trial protocol: Acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2).

Contemporary clinical trials·2026
Same author

Substance use and menopausal hormone therapy: Treatment initiation and interruption among US women with and without HIV, 2008-2019.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Related Experiment Video

Updated: Sep 26, 2025

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

10.0K

CD8 T Cell Virus Inhibition Assay Protocol.

Yinyan Xu1, Ann Marie Weideman2,3, Maria Abad-Fernandez1

  • 1Department of Microbiology & Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Bio-Protocol
|April 18, 2022
PubMed
Summary

The viral inhibition assay (VIA) was improved with independent replicate cultures for better reproducibility in measuring CD8+ T cell HIV control. This enhances clinical testing of HIV vaccines and therapies.

Keywords:
CD4CD8HIVJRCSFT-cellVirus inhibitionp24

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

22.8K
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.2K

Related Experiment Videos

Last Updated: Sep 26, 2025

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

10.0K
Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

22.8K
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

14.2K

Area of Science:

  • Immunology
  • Virology
  • Clinical Research

Background:

  • The human immunodeficiency virus (HIV)-1 viral inhibition assay (VIA) assesses CD8+ T cell-mediated inhibition of HIV replication in CD4+ T cells.
  • This assay is crucial for clinical testing of HIV vaccines and immunotherapies, but variations exist in protocols and readouts.
  • Existing VIA protocols differ in culture duration, CD4+ T cell purity, HIV strains used, and methods for quantifying viral inhibition.

Purpose of the Study:

  • To describe modifications to a 7-day VIA protocol to improve assay reproducibility.
  • To introduce independent replicate cultures for HIV-infected CD4+ T cells (HIV-CD4) and HIV-CD4:CD8 T cell cultures.
  • To identify methodological and analysis changes for enhanced assay performance.

Main Methods:

  • Modified a 7-day VIA protocol, emphasizing independent replicate cultures for HIV-CD4 and HIV-CD4:CD8 T cell cultures.
  • Quantified virus inhibition using a ratio of weighted averages of p24+ cells in replicate cultures.
  • Calculated 95% confidence intervals for inhibition measurements.

Main Results:

  • Introduction of independent replicate cultures significantly improved assay reproducibility.
  • Virus inhibition by CD8 T cells in people living with HIV (PLWH) on antiretroviral therapy (ART) remained largely stable over time.
  • Identified specific methodological and analysis changes applicable to other VIA protocols.

Conclusions:

  • The modified VIA protocol enhances reproducibility for assessing CD8+ T cell-mediated HIV inhibition.
  • The stability of CD8 T cell inhibition in PLWH on ART supports the assay's utility for evaluating therapeutic interventions.
  • These improvements facilitate more reliable clinical testing of HIV vaccines and immunotherapies.